US Patent Issued to The Regents of the University of Michigan on Dec. 16 for "Use of soluble urokinase plasminogen activator receptor levels to indicate prevention of cardiovascular disease with a statin" (Michigan Inventor)

ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,498,364, issued on Dec. 16, was assigned to The Regents of the University of Michigan (Ann Arbor, Mich.).

"Use of soluble urokinase plasminogen activator receptor levels to indicate prevention of cardiovascular disease with a statin" was invented by Salim Hayek (Ann Arbor, Mich.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure is directed to methods for preventing or treating cardiovascular disease and kidney dysfunction in certain patient populations which involve determining the level of soluble urokinase plasminogen activator receptor (suPAR) protein in a sample obtained from a subject, and performing various therapeutic interventions ba...